Advancing research in eye health, visual sciences, ophthalmic diagnosis, clinical treatment, surgical innovation and vision preservation.
The Department of Ophthalmology of The Gazette of Medical Sciences (The GMS) publishes peer-reviewed, open-access scholarly work addressing the prevention, diagnosis, management and treatment of eye diseases and visual disorders. The Department provides an international platform for ophthalmologists, optometrists, vision scientists, clinicians and researchers to communicate advances in clinical ophthalmology, ocular surgery, visual sciences and related biomedical research.
The Department welcomes original clinical and experimental research, prospective and retrospective studies, systematic and narrative reviews, case reports, case series, clinical observations, surgical techniques, technical innovations and scholarly perspectives. Contributions may address ocular anatomy and physiology, disease mechanisms, diagnostic technologies, pharmacological therapies, laser treatments, ophthalmic devices and surgical interventions.
Particular interest is given to research that advances early detection, improves treatment outcomes, supports patient safety and preserves or restores vision. The Department encourages studies in retinal and vitreous disorders, glaucoma, corneal and external eye diseases, cataract and refractive surgery, neuro-ophthalmology, ocular oncology, pediatric ophthalmology, ocular trauma, low vision and visual rehabilitation.
The Department also welcomes interdisciplinary research involving genetics, molecular biology, ophthalmic imaging, biomedical engineering, artificial intelligence, public health and vision-related quality of life. Studies addressing access to eye care, patient education, treatment adherence and improvements in clinical service delivery are within its scope.
The Department supports responsible scientific publishing, research integrity and ethical reporting. Submissions undergo editorial assessment and peer review in accordance with the journal's applicable editorial and publication policies.
Extramedullary plasmacytoma is a rare disease, characterized histopathologically by infiltration of plasma cells of different maturities and producing monoclonal immunoglobulin outside the bone marrow. J.R.G., 52 years old, male, sought medical assistance due to amaurosis and blocked eye movements.
View / Download Article ↗We report the laboratory results of conjunctival RT-PCR tests and some clinical features of these patients infected with COVID 19 in Shenyang, China. We collected conjunctival samples of the patients to do the laboratory tests by RT-PCR Medical observed patients were enrolled if they had clinical symptoms.
View / Download Article ↗This retrospective study analysed patients diagnosed as penetrating ocular traumatic endophthalmitis between January 2016 to January 2019 at a hospital, Liaoning province, China. Epidemiological data including age, gender, traumatic agents, time from trauma to endophthalmitis onset, culture results, treatment, visual acuity and prognosis. Risk factor analysis was used to compare presented data.
View / Download Article ↗This report describes a complication of symptoms consistent with transiency visual acuity damage and hearing injury following sclerotherapy with a polidocanol injection to a facial vascular malformation. After the direct injection of 5cc polidocanol-room air emulsion into the subcutaneous malformation, a 3-year-old boy developed bilateral eyelid swelling the next day, and on 7 days later at referral, visual acuity in the left eye was light perception.
View / Download Article ↗Please direct any enquiry or submit papers to: info@thegms.co
